From TIME magazine:
Research suggests that the psychedelic drug MDMA, an empathogenic stimulant also known as Molly or ecstasy, can spark changes in the brain that induce a childlike state of neuroplasticity and help forge new neural connections.
(It could well be approved for PTSD by the U.S. Food and Drugs Administration in August after two advanced stage trials showed significant benefits.)
Researchers are also studying other psychedelics as well, like the powerful drug ibogaine.
Read more
MDMA therapy for PTSD could become a new treatment option for millions of people living with trauma. The clinical evidence is growing.
Read more
Reports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.
Read more
A growing list of athletes are looking to psychedelic substances for healing brain trauma.
Read more
Here are the latest thoughts from author Paul Levy, on wounds as the path to awakening.
Read more
Traumatic events such as pandemics can spur transformative psychological growth.
Read more